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Abstract
Introduction: The existence of a graft-versus-lymphoma effect is well established. When lacking
a firm diagnosis, however, the clinician is challenged to to weigh the potential benefits of the graft-
versus-lymphoma effect against potential dangers of graft-versus-host disease as well as against
generalized (viral) infections.
Case presentation: We present evidence for a graft-versus-lymphoma effect in a 64-year-old
caucasian woman with a transplanted peripheral blood-stem-cell graft from her Human Leukocyte
Antigen-identical sister, and propose diagnostic measures to distinguish between graft-versus-host
effect, and against viral disease or drug-induced reactions.
Conclusion: We were able to identify an allogeneic graft-reaction against progressive lymphoma
alongside an erythema consistent with acute graft-versus-host disease of the skin. Establishing a firm
diagnosis enabled us to decide against T-cell suppression (such as by using cyclosporine). Anti-
lymphoma activity was favoured, by means of the allogeneic graft, local radiation and
immunotherapy. This illustrates the importance of a sound differential diagnosis of erythema after
allogeneic stem-cell transplantation, including assessment of viral disease of the affected tissue.
Introduction
The existence of a graft-versus-lymphoma effect is well
established. Its clinical significance is less clear and seems
to depend on the type of lymphoma and on the disease
status [1]. A graft-versus-lymphoma effect frequently coin-
cides with graft-versus-host disease. Assessment of graft-
versus-host disease is commonly obscured by concomi-
tant diseases, e.g. viral or drug-induced exanthema [2,3],
viral hepatitis or viral gastroenteritis. The crucial decision
is if, when and to which extent an immunosuppressant
should be administered. Lacking a firm diagnosis, the
challenge for the clinician is to outweigh potential bene-
fits of the graft-versus-lymphoma effect against potential
dangers of graft-versus-host disease as well as against gen-
eralized viral infections.
Case presentation
A 64-year-old female patient received a peripheral blood-
stem-cell graft from her Human Leukocyte Antigen
(HLA)-identical sister in the course of a refractory lym-
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phoplasmacytic lymphoma. Conditioning consisted of 7
Gy total body irradiation (2 × 2 Gy d-8, 1 × 3 Gy d-7), 120
mg/m2 fludarabin (30 mg/m2 d-7 – d-4) and cyclophos-
phamide 60 mg/kg (30 mg/kg, d-4 – d-3). During condi-
tioning, the lymphoma progressed and histology showed
transformation into an aggressive lymphoma. In the
course of the disease, the patient rapidly developed new
small, callous subcutaneous nodules. Radiation as well as
immunotherapy (anti-CD20-antibody, rituximab) was
administered and immunosuppression discontinued.
Unfortunately, growth of the lymphomatous lesions
could not be halted by these means. After the patient had
engrafted, a progressive erythema, predominantly sur-
rounding the novel subcutaneous nodules, evolved and
was followed by massive diarrhea, prompting the differ-
ential diagnosis of acute graft-versus-host disease versus
viral disease. A skin biopsy in proximity to a subcutaneous
nodule surprisingly not only showed a polymerase chain
reaction (PCR) positive for Epstein-Barr Virus (EBV) but
also histologic findings of both lymphoma and graft ver-
sus lymphoma (Figure 1). Unfortunately, the patient died
of multiple organ failure following sepsis with multiple
causative organisms, including EBV, Cytomegalovirus
(CMV) and gram negative bacteria.
Conclusion
To summarize, we were able to identify an allogeneic graft
reaction against progressive lymphoma as the cause of the
observed erythema. We therefore were able to decide
against T-cell-suppression, for example by cyclosporine,
favouring anti-lymphoma activity by means of the alloge-
neic graft, local radiation and immunotherapy. We were
not able to establish the relevance of a positive EBV PCR
detected in proximity to the subcutaneous nodules in the
skin. Notably, the skin biopsies stained negative for latent
membrane protein 1 (LMP1), making a post-transplanta-
tion lymphoproliferative disease less likely than a mere
transformation of the indolent into an aggressive lym-
phoma.
This case report illustrates the importance of a sound dif-
ferential diagnosis of erythema after allogeneic stem-cell
transplantation, including assessment of viral disease of
the affected tissue with PCR as well as histology.
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Lymphoma infiltration spreading subcutaneously accompa-nied by a lichenoid inflamm tionFigure 1
Lymphoma infiltration spreading subcutaneously 
accompanied by a lichenoid inflammation.Page 2 of 2
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